>>>> Stock Option Playaz <<<<

[umiak]

SUPN DEC calls cheap cheap cheap. The volatility is for slow growth like PFE not a low float pharma with newly approved drugs. Just beginning growth ...SUPN reminds me of ACAD only they have less than half the os, 1/4 the float, a $.7B market FDA approved Epilepsy drug(time release) being marketed in house and another with FDA tentative approval to launch in Q3(2.7B market)!!!!

June presentation:

Sales force focused on increasing call frequency
- On average 600 calls per week in early weeks increased to 1300 calls
in most recent week

http://files.shareholder.com/downloads/ABEA-5ZNGZM/2528974113x0x668312/9d695015-3a3f-4fd3-b76b-f5b6dba68a0d/Supernus%20Presentation%20Jefferies%20Conference%20June%202013.pdf